Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleural SC5b-9: a test for identifying complicated parapneumonic effusions.

M Vives1, J M Porcel, I Gázquez

  • 1Department of Internal Medicine, University Hospital Arnau de Vilanova, University of Lleida, Spain. jporcelp@medynet.com

Respiration; International Review of Thoracic Diseases
|August 15, 2000
PubMed
Summary

Complement activation products SC5b-9 and C3a-desArg can help differentiate complicated parapneumonic effusions (CPE) from uncomplicated ones (UPE). Measuring pleural SC5b-9 shows promise for diagnosing CPE in patients with parapneumonic effusions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventing lung function decline and pleural thickening after pleural TB: a systematic review.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026
Same author

MEYER project: Towards a national protocol for in vivo measurement of <sup>131</sup>I in the thyroid of exposed populations in emergencies.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same author

Clinical characteristics and management of Spanish adult patients with phenylketonuria.

Revista clinica espanola·2025
Same author

Edaphic and meteorological parameters as determinants of radon exhalation and its environmental implication in Peruvian agroecosystems.

Scientific reports·2025
Same author

Yield of ultrasound-guided biopsies of focal lesions in an Internal Medicine Department.

Revista clinica espanola·2025
Same author

[Translated article] Consensus Statement From the Spanish Academy of Dermatology and Venereology (AEDV) Psoriasis Working Group (SWG) and Pediatric Working Group (PWG) on the Management of Pediatric Psoriasis.

Actas dermo-sifiliograficas·2024

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Diagnostic Biomarkers

Background:

  • Parapneumonic effusions (PPE) are common complications of pneumonia.
  • Distinguishing complicated parapneumonic effusions (CPE) from uncomplicated parapneumonic effusions (UPE) is crucial for appropriate management.
  • Current diagnostic methods may not always be definitive.

Purpose of the Study:

  • To evaluate the utility of complement activation products, specifically SC5b-9 and C3a-desArg, in differentiating CPE from UPE.
  • To assess the diagnostic accuracy of these biomarkers in patients with parapneumonic effusions.

Main Methods:

  • A study involving 66 patients with various pleural effusions (empyema, CPE, UPE, transudates) was conducted.
  • Pleural fluid levels of SC5b-9 and C3a-desArg were measured using commercial ELISA kits.

Related Experiment Videos

  • Receiver operating characteristic (ROC) analysis was employed to evaluate the performance of these markers.

    • Main Results:

    • Patients with CPE exhibited significantly higher mean pleural SC5b-9 and C3a-desArg levels compared to those with UPE (p < 0.0001).
    • Pleural SC5b-9 and C3a-desArg demonstrated high diagnostic accuracy for CPE (90.3% and 77.8%, respectively) at specific cutoff points.
    • A combination of SC5b-9, LDH, and pleural polymorphonuclear percentage yielded the highest discriminative power for CPE diagnosis (AUC 0.97).

    Conclusions:

    • Pleural fluid SC5b-9 measurement appears to be a valuable tool in the diagnostic workup of parapneumonic effusions.
    • This biomarker can aid in distinguishing complicated from uncomplicated parapneumonic effusions.
    • Further investigation is warranted to confirm these findings in larger cohorts.